Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02724631 · ClinicalTrials.gov registry record · NA
TubeClear® Evaluation in Pediatric Patients (Phase I)
A NA study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02724631 is a NA study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 1 participants.
The verdict
NCT02724631, a NA study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is the first of three planned phases designed to evaluate the feasibility and tolerability of TubeClear® to restore patency in occluded Pediatric Enteral Access Devices. Based on preliminary data obtained from this phase of the study, subsequent phases will continue to evaluate feasibility and tolerability (Phase IIA) and ultimately compare efficacy of TubeClear® to the Children's Hospital of Philadelphia (CHOP) Standard Treatment to restore patency in occluded Pediatric Enteral Access Devices (EAD) (Phase IIB).
Interventions
- DEVICE TubeClear® intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02724631
The ClinicalTrials.gov registry entry for NCT02724631 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TubeClear® intervention is the first listed.
NCT02724631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02724631 about?
NCT02724631 is a clinical study titled "TubeClear® Evaluation in Pediatric Patients (Phase I)". This is the first of three planned phases designed to evaluate the feasibility and tolerability of TubeClear® to restore patency in occluded Pediatric Enteral Access Devices. Based on preliminary data obtained from this phase of the study, subsequent phases will continue to evaluate feasibility and ...
What is the current status of trial NCT02724631?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-11. Estimated completion is 2020-07-07.
What interventions are being tested in trial NCT02724631?
The interventions under investigation include: TubeClear® intervention (DEVICE).
Who is sponsoring clinical trial NCT02724631?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.